Last viewed: LLY


Prices are updated after-hours



nyse:LLY Eli Lilly and Company

LLY | News S | $317.62 -2.95% -0.03% | twitter stocktwits trandingview |
Health Technology

(0.0% 1d) (-0.2% 1m) (38.4% 1y) (0.0% 2d) (-1.9% 3d) (2.7% 7d) (NaN% volume)
Earnings Calendar:
http://www.lilly.com
Sec Filling | Patents | 33625 employees

(US) Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. Its products include Forteo, Adrica, BAQSIMI, Basaglar and Glucagn. The company was founded by Eli Lilly on May 1876 and is headquartered in Indianapolis, IN.



Drugs
Alimta (Pemetrexed disodium)
Amyvid (Florbetapir F 18)
Bamlanivimab (Bamlanivimab)
Baqsimi (glucagon)
BASAGLAR KwikPen (Insulin glargine)
BASAGLAR Tempo Pen (Insulin glargine)
Cialis (Tadalafil)
Cymbalta (Duloxetine hydrochloride)
CYRAMZA (ramucirumab)
Effient (Prasugrel hydrochloride)
EMGALITY (galcanezumab-gnlm)
Etesevimab (Etesevimab)
Evista (Raloxifene hydrochloride)
Forteo (Teriparatide)
Gemzar (Gemcitabine hydrochloride)
Glucagon (glucagon)
Humalog (Insulin lispro)
Humalog Junior KwikPen (Insulin lispro)
Humalog KwikPen (Insulin lispro)
Humalog Mix50/50 (Insulin lispro)
Humalog Mix50/50 KwikPen (Insulin lispro)
Humalog Mix75/25 (Insulin lispro)
Humalog Mix75/25 KwikPen (Insulin lispro)
Humalog Tempo Pen (Insulin lispro)
HUMATROPE (Somatropin)
Humulin 70/30 (Insulin human)
Humulin 70/30 KwikPen (Insulin human)
Humulin N (Insulin human)
Humulin R (Insulin human)
Humulin R U-500 (Insulin human)
Humulin R U-500 KwikPen (Insulin human)
Insulin Lispro (Insulin lispro)
Insulin Lispro Junior KwikPen (Insulin lispro)
Insulin Lispro KwikPen (Insulin lispro)
Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 KwikPen (Insulin lispro)
LARTRUVO (olaratumab)
LYUMJEV (Insulin lispro-aabc)
LYUMJEV Junior KwikPen (Insulin lispro-aabc)
LYUMJEV KwikPen (Insulin lispro-aabc)
LYUMJEV Tempo Pen (Insulin lispro-aabc)
Olumiant (baricitinib)
Portrazza (necitumumab)
RETEVMO (selpercatinib)
Reyvow (lasmiditan)
Sterile Diluent (diluent)
Strattera (Atomoxetine hydrochloride)
Symbyax (Olanzapine and Fluoxetine hydrochloride)
TALTZ (ixekizumab)
TAUVID (Flortaucipir F-18)
Trulicity (Dulaglutide)
Verzenio (abemaciclib)
Zyprexa (Olanzapine)
ZYPREXA Intramuscular (Olanzapine)
ZYPREXA Relprevv (Olanzapine pamoate)
ZYPREXA Zydis (Olanzapine)

add to watch list email alert is off

Price chart


% (High / Open) change chart




Press-releases


Innovent Announces Phase 1b Study Results of Mazdutide (IBI362) in Chinese Patients with Type 2 Diabetes Published in Nature Communications
Published: 2022-06-29 (Crawled : 01:00) - prnewswire.com
LLY | News S | $317.62 -2.95% -0.03% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
INCY | News | $75.64 -2.22% 0.93% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

ibi362 communications chinese diabetes results
Akoya Biosciences to Partner with Acrivon Therapeutics for the Clinical Development of Acrivon’s Proprietary OncoSignature® Test into a Companion Diagnostic
Published: 2022-06-28 (Crawled : 12:20) - globenewswire.com
LLY | News S | $317.62 -2.95% -0.03% | twitter stocktwits trandingview |
Health Technology
| | O: 0.99% H: 0.0% C: 0.0%
AKYA | News | $12.61 4.73% 1.83% | twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: 7.52% H: 4.77% C: 3.37%

oncosignature for test diagnostic therapeutics
Global Clinical Trials Markets 2022-2028: Globalization of Clinical Trials / Increasing R&D Promoting Outsourcing / Adoption of New Technology in Clinical Research
Published: 2022-06-28 (Crawled : 11:00) - prnewswire.com
ICLR | News | $219.14 -0.79% 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: 1.05% H: 0.96% C: -0.24%
LLY | News S | $317.62 -2.95% -0.03% | twitter stocktwits trandingview |
Health Technology
| | O: 0.99% H: 0.0% C: 0.0%
NVO | News | $108.3 -4.07% 2.17% | twitter stocktwits trandingview |
Health Technology
| | O: -2.98% H: 0.66% C: -0.87%

trials research technology
MSP Recovery Commences Billing Big Pharma More Than $5.6 Billion In Billed Amounts and More Than $2.8 Billion In Paid Amounts
Published: 2022-06-28 (Crawled : 02:00) - globenewswire.com
SNY | News | $52.13 -0.89% 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: -0.27% H: 0.06% C: -0.82%
ABBV | News | $152.49 -0.42% 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: 0.06% H: 1.27% C: -0.44%
LLY | News S | $317.62 -2.95% -0.03% | twitter stocktwits trandingview |
Health Technology
| | O: 0.99% H: 0.0% C: 0.0%

pharma
DTx Pharma Appoints Peter Condon as Chief Business Officer
Published: 2022-06-28 (Crawled : 12:00) - biospace.com/
LLY | News S | $317.62 -2.95% -0.03% | twitter stocktwits trandingview |
Health Technology
| | O: 0.99% H: 0.0% C: 0.0%

pharma
Innovent Announces Phase 1b Study Results of Mazdutide (IBI362) in Chinese Patients with Type 2 Diabetes Published in Nature Communications
Published: 2022-06-28 (Crawled : 01:00) - biospace.com/
LLY | News S | $317.62 -2.95% -0.03% | twitter stocktwits trandingview |
Health Technology
| | O: 0.99% H: 0.0% C: 0.0%
INCY | News | $75.64 -2.22% 0.93% | twitter stocktwits trandingview |
Health Technology
| | O: -0.08% H: 0.0% C: 0.0%

ibi362 communications chinese diabetes results
Cancer Immunotherapy Market Expands with Rising Adoption of Target Therapy in Cancer Treatment, States TMR Report
Published: 2022-06-27 (Crawled : 16:00) - prnewswire.com
AZNCF | $127.2501 | twitter stocktwits trandingview |
Health Technology
| | O: -1.55% H: 4.43% C: 0.03%
NVS | $84.17 -1.3% 0.17% | twitter stocktwits trandingview |
Health Technology
| | O: 1.86% H: 1.05% C: 0.24%
LLY | News S | $317.62 -2.95% -0.03% | twitter stocktwits trandingview |
Health Technology
| | O: 1.32% H: 0.0% C: 0.0%
GSK | $43.35 -0.8% 0.19% | twitter stocktwits trandingview |
Health Technology
| | O: -0.16% H: 0.61% C: 0.18%
GLAXF | $21.99 | twitter stocktwits trandingview |
Health Technology
| | O: 0.47% H: 3.73% C: 3.73%
PFE | News | $50.66 -2.35% 0.4% | twitter stocktwits trandingview |
Health Technology
| | O: 1.46% H: 1.45% C: 0.78%
SPPI A | $0.8436 -1.91% 1.74% | twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 2.28% C: -2.27%
SNYNF | News | $108.84 | twitter stocktwits trandingview |
Health Technology
| | O: 4.15% H: 0.0% C: 0.0%
BMY | $78.7 -1.6% 0.38% | twitter stocktwits trandingview |
Health Technology
| | O: 0.78% H: 1.72% C: 0.95%
SNY | News | $52.13 -0.89% 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: 0.53% H: 0.0% C: 0.0%
AZN | $65.94 -0.86% 0.21% | twitter stocktwits trandingview |
Health Technology
| | O: -0.36% H: 1.22% C: 0.38%

immunotherapy report therapy cancer market
Innovent and Lilly Jointly Announce the Approval of TYVYT® (sintilimab injection) by China NMPA in Combination with Chemotherapy as First-line Treatment of Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Published: 2022-06-27 (Crawled : 01:00) - prnewswire.com
LLY | News S | $317.62 -2.95% -0.03% | twitter stocktwits trandingview |
Health Technology
| | O: 1.32% H: 0.0% C: 0.0%
INCY | News | $75.64 -2.22% 0.93% | twitter stocktwits trandingview |
Health Technology
| | O: 3.36% H: 0.35% C: -0.71%

tyvyt treatment approval china
Lilly Declares Third-Quarter 2022 Dividend
Published: 2022-06-27 (Crawled : 21:00) - biospace.com/
LLY | News S | $317.62 -2.95% -0.03% | twitter stocktwits trandingview |
Health Technology
| | O: 1.32% H: 0.0% C: 0.0%


Veru Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Published: 2022-06-24 (Crawled : 21:00) - globenewswire.com
LLY | News S | $317.62 -2.95% -0.03% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
VERU | $11.81 -8.17% -0.23% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

nasdaq grants
See all


Last 15 days Sec forms
File Id Form Published Date Transaction Date Direction Code Amount Transacted Owned Amount
0001209191-22-039569 4 2022-06-28 2022-06-27 Sell S 41857 104161953
0001209191-22-039153 4 2022-06-24 2022-06-23 Sell S 62 104418810
0001209191-22-039153 4 2022-06-24 2022-06-23 Sell S 83851 104418872
0001209191-22-039153 4 2022-06-24 2022-06-23 Sell S 25526 104502723
0001209191-22-039153 4 2022-06-24 2022-06-23 Sell S 35274 104528249
0001209191-22-039153 4 2022-06-24 2022-06-23 Sell S 60287 104563523
0001209191-22-038833 4 2022-06-23 2022-06-22 Sell S 9119 104623810
0001209191-22-038833 4 2022-06-23 2022-06-22 Sell S 18603 104632929
0001209191-22-038833 4 2022-06-23 2022-06-22 Sell S 67330 104651532
0001209191-22-038833 4 2022-06-23 2022-06-22 Sell S 80923 104718862
0001209191-22-038833 4 2022-06-23 2022-06-22 Sell S 34025 104799785
0000059478-22-000175 4 2022-06-22 2022-06-21 Buy A 33 69497


Your Today's Watch List
Sign in to create a watchlist
Last 48 Hours Insiders Buying
ALTG P 3227 | $9.29 -2.52% 0.0% | twitter stocktwits trandingview |
Distribution Services
| 01:40
SKIL P 30000 | $3.61 -6.96% 0.0% | twitter stocktwits trandingview |
Information
| 23:50
CAMP P 20000 | $4.65 -1.27% -0.43% | twitter stocktwits trandingview |
Electronic Technology
| 16:00